govt.fyi
Back to SB 231
West Virginia Legislature· SB 231Signed

Relating to value-based payment requirements, the official text

Shown verbatim: the complete text as captured from the official PDF posted by the West Virginia Legislature, fetched 2026-09-25. Page and line markers are part of the official record; nothing is edited or removed. The official bill page.
WEST VIRGINIA LEGISLATURE

         2026 REGULAR SESSION

                     Enrolled
            Committee Substitute

                         for
            Committee Substitute

                         for

           Senate Bill 231

     BY SENATORS HELTON, ROSE, TAYLOR, RUCKER, DEEDS,
                           BARTLETT, AND WILLIS

         [Passed March 14, 2026; in effect 90 days from
                        passage (June 12, 2026)]
    Enr CS for CS for SB 231

1 AN ACT to amend the Code of West Virginia, 1931, as amended, by adding a new article,

2   designated §9-11-1, §9-11-2, §9-11-3, §9-11-4, §9-11-5, and §9-11-6, relating to value-

3   based payment requirements; providing legislative intent; defining terms; establishing

4   value-based measures; creating timelines for implementation; setting out authority; and

5   making provision inoperable without approval.

    Be it enacted by the Legislature of West Virginia:

    ARTICLE 11. ADDICTION CARE RECOVERY OUTCOMES.

    §9-11-1. Legislative findings and purpose.

1   The Legislature finds that West Virginia continues to be severely impacted by substance

2 use disorder and overdose deaths. While the state has made substantial investments in

3 treatment, recovery, and prevention, the current addiction care system is fragmented and not

4 aligned to measurable long-term recovery outcomes. The purpose of this article is to reorganize

5 the state’s addiction care system into a value-based continuum of care and incentivize

6 coordination, integration, and accountability for recovery success.

    §9-11-2. Definitions.

1   As used in this article:

2   “Baseline year” means the designated time period during which performance data,

3 including, but not limited to, cost, quality, utilization, and outcome-based performance measures

4 is collected to establish benchmarks.

5   "Continuum of care" means a coordinated system of services that includes prevention,

6 early intervention, treatment (including withdrawal management and medication-assisted

7 treatment), recovery support, supportive housing, vocational and educational support, and peer

8 services. The continuum shall address the needs of individuals at all stages of substance use

9 disorder and recovery.

10  "Value-based payment" means a payment model that incentivizes providers for quality

11 and cost-effective care and reduces payments to providers who fail to meet specified metrics,

                                                1
    Enr CS for CS for SB 231

12 shifting from paying for volume (fee-for-service) to paying for patient health outcomes and

13 experiences. This payment model shall include performance-based payments tied to specific

14 outcomes identified in this article.

    §9-11-3. Establishment of value-based measures.

1   (a) On or before October 1, 2026, the Bureau for Medical Services, in conjunction with

2 their managed care organizations, shall establish standard billing codes for all substance use

3 disorder services to be used by providers in the continuum of care on or before January 15, 2027.

4   (b) The Bureau for Medical Services shall collect data from all providers in the continuum

5 of care regarding billing codes and other measures to be collected by providers as set forth in this

6 article for analysis purposes to determine utilization trends, costs, and outcomes by provider.

7   (c) The Bureau for Medical Services shall analyze the data for utilization and costs trends.

8 After the outcome measures are determined as set forth in this article, the Bureau for Medical

9 Services shall collect and analyze the measures to improve quality in the Medicaid program and

10 determine how to establish value-based payments to incentivize quality substance use disorder

11 outcomes. Any trends indicating overutilization or overbilling shall be referred to the Medicaid

12 Fraud Control Unit.

13  (d) The Bureau for Medical Services shall submit a report to the Legislative Oversight

14 Commission on Health and Human Resources Accountability on before January 1, 2028, and

15 annually thereafter, regarding substance use disorder utilization trends and costs by provider and

16 provider type. All providers shall be given an anonymized synthetic identifier in the report to allow

17 trends to be followed in multiple years. Once the outcome measures are developed, this report

18 shall further include outcomes by provider and provider type. The outcome portion of this report

19 shall first be included on July 1, 2028, and be reported annually thereafter. All reports shall

20 contain a comparison of state utilization, cost, and outcomes to the previous fiscal year’s data to

21 also include, but not be limited to, the rate for neonatal abstinence syndrome and statewide adult

                                         2
    Enr CS for CS for SB 231

22 deaths. This analysis shall also include a comparison of utilization, cost, outcomes, the rate of

23 neonatal abstinence, and adult death rates to a national rate.

24  (e) On or before July 1, 2026, the Bureau for Medical Services, in consultation with the

25 Bureau for Behavioral Health, relevant state agencies, Marshall University, Joan C. Edwards

26 School of Medicine, West Virginia University School of Medicine Behavioral Health Faculty,

27 individuals in recovery, providers, law enforcement, and other relevant stakeholders, shall

28 develop a set of outcome-based performance measures for each level of care within the addiction

29 treatment and recovery services care continuum.

    §9-11-4. Use of value-based measures.

1   (a) The measures to be utilized under value-based programs shall include, but not be

2 limited to, the following:

3   (1) Housing stability — which means whether the individual is in stable, safe, and long-

4 term housing;

5   (2) Sobriety — which means verified abstinence from non-prescribed substances or

6 effective management thorough medication-assisted treatment;

7   (3) Criminal justice and child welfare avoidance — which means no new arrests, law-

8 enforcement interactions, or Child Protective Services investigations, indicating improvement in

9 the societal burden of their addiction and costs to other governmental agencies;

10  (4) Self-sufficiency — which means participation in employment, education, training

11 programs, or other activities indicative of long-term recovery and independence, indicating a

12 reduction in dependence on governmental benefits; and

13  (5) Provider transition plan — which means the development and implementation by a

14 provider of a concrete plan to assist an individual moving between different settings or providers.

15  (b) These metrics developed pursuant to this article shall be:

16  (1) Measurable and capable of validation using existing or enhanced state data systems

17 or data input from outside providers;

                                           3
    Enr CS for CS for SB 231

18  (2) Inclusive of the delivery of services to address the social determinants of health;

19  (3) Account for individual complexity and acuity and may include different tiers of

20 performance measures and incentive models based on comorbidity and severity; and

21  (4) Protective of privacy and consistent with the Health Insurance Portability and Insurance

22 Act and other relevant state and federal regulations.

    §9-11-5. Implementation of value-based payment model.

1   (a) The baseline year will begin on or before July 1, 2027, and continue for a one-year

2 time period during which time performance data, including, but not limited to, cost, quality,

3 utilization, and the outcome-based performance measures, shall be collected and analyzed to

4 establish benchmarks. These benchmarks shall be provided to providers to allow them to

5 improve performance during the baseline year.

6   (b) On or before July 1, 2028, the Bureau for Medical Services shall require the managed

7 care organizations to provide a value-based payment in conformity with the approved outcome

8 measures and standard billing codes set forth in and developed pursuant to this article.

    §9-11-6. Centers for Medicare and Medicaid Authority.

1   (a) On or before October 1, 2026, the Bureau for Medical Services, to the extent

2 necessary, shall submit a state plan amendment for the appropriate Center for Medicare and

3 Medicaid Services (CMS) authority to implement any payment and coverage changes necessary

4 to effectuate this article. The amendment shall include, but not be limited to:

5   (1) Development of the value-based payment model, which shall include, but not be limited

6 to, enhanced payments for provider outcomes for meeting or exceeding the outcome measures

7 as set forth in this article and reduces payments to providers who fail to meet outcome measures;

8   (2) The payment model shall account for a baseline year in which data is collected,

9 communicated to providers to allow notice of performance, and to establish the baseline;

10  (3) The model shall allow for an annual review of performance measures to permit

11 flexibility and to address quality outcomes;

                                                 4
    Enr CS for CS for SB 231

12  (4) Provisions for a provider to be de-certified, to have specific code blocked, to be

13 terminated, or otherwise be excluded from the Medicaid program when the provider fails to meet

14 the established outcome measures for three consecutive quarters;

15  (5) Specific performance measures; and

16  (6) System-level outcomes that the performance-based model shall produce with common

17 return-on-health-investment measures that can be used to compare the investments in a specific

18 system of care relative to the outcomes.

19  (b) The provisions of this article shall have no force or effect if CMS does not approve the

20 state plan amendment as required by this section.

                                             5
Enr CS for CS for SB 231
              The Clerk of the Senate and the Clerk of the House of Delegates hereby

         certify that the foregoing bill is correctly enrolled.
         ...............................................................

                       Clerk of the Senate
                           ...............................................................
                               Clerk of the House of Delegates

         Originated in the Senate.
         In effect 90 days from passage.

                                       ...............................................................
                                                 President of the Senate
                                                           ...............................................................
                                                              Speaker of the House of Delegates
                                                        __________

              The within is ................................................ this the...........................................
         Day of ..........................................................................................................., 2026.

                                                                   .............................................................
                                                                                         Governor

                                                               7
Every fact on this page links to its source, starting with the official bill record.